Cargando…

14-3-3η is a novel mediator associated with the pathogenesis of rheumatoid arthritis and joint damage

INTRODUCTION: The aim of this study was to investigate whether 14-3-3η, a specific isoform of a family of proteins regulating processes such as cellular signalling, activates cell-signalling pathways and induces factors known to contribute to the pathophysiology of rheumatoid arthritis (RA). We also...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maksymowych, Walter P, van der Heijde, Désirée, Allaart, Cornelia F, Landewé, Robert, Boire, Gilles, Tak, Paul P, Gui, Yuan, Ghahary, Aziz, Kilani, Ruhangiz, Marotta, Anthony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060379/ https://www.ncbi.nlm.nih.gov/pubmed/24751211 http://dx.doi.org/10.1186/ar4547

Ejemplares similares

Serum levels of 14-3-3η protein supplement C-reactive protein and rheumatoid arthritis-associated antibodies to predict clinical and radiographic outcomes in a prospective cohort of patients with recent-onset inflammatory polyarthritis
por: Carrier, Nathalie, et al.
Publicado: (2016)

Evaluating the Biocompatibility of an Injectable Wound Matrix in a Murine Model
por: Alnojeidi, Hatem, et al.
Publicado: (2022)

M-CSF-stimulated myeloid cells can convert into epithelial cells to participate in re-epithelialization and hair follicle regeneration during dermal wound healing
por: Li, Yunyuan, et al.
Publicado: (2022)

A prospective cohort study of 14-3-3η in ACPA and/or RF-positive patients with arthralgia
por: van Beers-Tas, Marian H., et al.
Publicado: (2016)

Anti-Scarring Properties of Different Tryptophan Derivatives
por: Poormasjedi-Meibod, Malihe-Sadat, et al.
Publicado: (2014)

IDO-expressing Fibroblasts Suppress the Development of Imiquimod-induced Psoriasis-like Dermatitis
por: Elizei, Sanam Salimi, et al.
Publicado: (2018)

Mechanism Underlying Defective Interferon Gamma-Induced IDO Expression in Non-obese Diabetic Mouse Fibroblasts
por: Hosseini-Tabatabaei, Azadeh, et al.
Publicado: (2012)

808 Combination of Adipose Micro Fragments and Liquid Scaffold Improve Wound Healing Outcomes
por: Sheikh-Oleslami, Sara, et al.
Publicado: (2022)

Serum 14-3-3η level is associated with severity and clinical outcomes of rheumatoid arthritis, and its pretreatment level is predictive of DAS28 remission with tocilizumab
por: Hirata, Shintaro, et al.
Publicado: (2015)

The Role of 14-3-3 η as a Biomarker in Rheumatoid Arthritis
por: Abdelhafiz, Dima, et al.
Publicado: (2021)

14-3-3η Promotes Invadosome Formation via the FOXO3–Snail Axis in Rheumatoid Arthritis Fibroblast-like Synoviocytes
por: Kadiri, Maleck, et al.
Publicado: (2021)

DAS steered therapy in clinical practice; cross-sectional results from the METEOR database
por: Gvozdenović, Emilia, et al.
Publicado: (2016)

Antibacterial Thermosensitive Silver–Hydrogel Nanocomposite Improves Wound Healing
por: Amiri, Nafise, et al.
Publicado: (2023)

The validity of a rheumatoid arthritis medical records-based index of severity compared with the DAS28
por: Landewé, Robert, et al.
Publicado: (2006)

Tumour necrosis factor alpha promotes secretion of 14-3-3η by inducing necroptosis in macrophages
por: Trimova, Gulzhan, et al.
Publicado: (2020)

Fibroblast cell-based therapy prevents induction of alopecia areata in an experimental model
por: Jalili, Reza B, et al.
Publicado: (2018)

Diagnostic accuracy of 14‐3‐3 η protein in rheumatoid arthritis: A meta‐analysis
por: Wang, Decai, et al.
Publicado: (2020)

14-3-3η protein is associated with disease activity and osteoporosis in patients with rheumatoid arthritis
por: Adel, Yasmin, et al.
Publicado: (2022)

Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes
por: Jalili, Reza B., et al.
Publicado: (2016)

Robust analyses for radiographic progression in rheumatoid arthritis
por: Landewé, Robert, et al.
Publicado: (2023)

When rheumatologists report that they agree with a guideline, does this mean that they practise the guideline in clinical practice? Results of the International Recommendation Implementation Study (IRIS)
por: Gvozdenović, Emilia, et al.
Publicado: (2016)

Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd study
por: van der Heijde, Désirée, et al.
Publicado: (2022)

The association among 14-3-3η protein, inflammation, bone remodeling and osteoporosis in patients with rheumatoid arthritis
por: Sun, Yi, et al.
Publicado: (2020)

Tumor Necrosis Factor Inhibitors Reduce Spinal Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: A Longitudinal Analysis From the Alberta Prospective Cohort
por: Sepriano, Alexandre, et al.
Publicado: (2021)

Association of the different types of radiographic damage with physical function in patients with rheumatoid arthritis: analysis of the RAPID trials
por: Gherghe, Ana Maria, et al.
Publicado: (2016)

Discontinuation rates of biologics in patients with rheumatoid arthritis: are TNF inhibitors different from non-TNF inhibitors?
por: Ramiro, Sofia, et al.
Publicado: (2015)

Serum levels of 14-3-3η are associated with increased disease risk, activity and duration of rheumatoid arthritis in Chinese patients
por: Tu, Jianxin, et al.
Publicado: (2020)

Existing joint erosions increase the risk of joint space narrowing independently of clinical synovitis in patients with early rheumatoid arthritis
por: Landewé, Robert, et al.
Publicado: (2015)

Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years
por: van der Heijde, Désirée, et al.
Publicado: (2009)

Inhibition of spinal bone formation in AS: 10 years after comparing adalimumab to OASIS
por: van der Heijde, Désirée, et al.
Publicado: (2019)

Prevalence and significance of serum 14–3-3η in juvenile idiopathic arthritis
por: Reyhan, Iris, et al.
Publicado: (2021)

Gastrodin Protects Cardiomyocytes from Anoxia/Reoxygenation Injury by 14-3-3η
por: Zhu, Meifang, et al.
Publicado: (2018)

14-3-3η Protein as a Potential Biomarker in Juvenile Idiopathic Arthritis
por: Dalrymple, Austin, et al.
Publicado: (2021)

Assessment of radiographic progression in patients with rheumatoid arthritis treated with tofacitinib in long-term studies
por: van der Heijde, Désirée, et al.
Publicado: (2020)

Structural damage in rheumatoid arthritis as visualized through radiographs
por: van der Heijde, Désirée
Publicado: (2002)

Will 14-3-3η Be a New Diagnostic and Prognostic Biomarker in Rheumatoid Arthritis? A Prospective Study of Its Utility in Early Diagnosis and Response to Treatment
por: Alashkar, Doaa Shawky, et al.
Publicado: (2022)

Comparison of the catalytic activity for the Suzuki–Miyaura reaction of (η(5)-Cp)Pd(IPr)Cl with (η(3)-cinnamyl)Pd(IPr)(Cl) and (η(3)-1-t-Bu-indenyl)Pd(IPr)(Cl)
por: Melvin, Patrick R, et al.
Publicado: (2015)

Effect of certolizumab pegol over 96 weeks of treatment on inflammation of the spine and sacroiliac joints, as measured by MRI, and the association between clinical and MRI outcomes in patients with axial spondyloarthritis
por: Braun, Jürgen, et al.
Publicado: (2017)

Is radiographic progression in modern rheumatoid arthritis trials still a robust outcome? Experience from tofacitinib clinical trials
por: Landewé, Robert B. M., et al.
Publicado: (2016)

An Actinide Zintl Cluster: A Tris(triamidouranium)μ(3)-η(2):η(2):η(2)-Heptaphosphanortricyclane and Its Diverse Synthetic Utility**
por: Patel, Dipti, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9bjcnngk1j1p3eac5epal0p684